Ardent Health downgraded by BofA Securities with a new price target
$ARDT
Hospital/Nursing Management
Health Care
BofA Securities downgraded Ardent Health from Neutral to Underperform and set a new price target of $14.60
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/17/2025 | Overweight → Sector Weight | KeyBanc Capital Markets | |
| 11/14/2025 | Overweight → Equal-Weight | Morgan Stanley | |
| 10/14/2025 | $19.00 | Neutral | Goldman |
| 9/10/2025 | $17.00 | Buy | UBS |
| 7/16/2025 | $14.60 | Neutral → Underperform | BofA Securities |
| 12/17/2024 | $20.00 | Neutral | Analyst |
| 11/6/2024 | $22.00 → $19.00 | Buy → Neutral | BofA Securities |
| 10/11/2024 | $24.00 | Overweight | KeyBanc Capital Markets |
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced it has partnered with hellocare.ai as its enterprise platform for AI assisted virtual physician, virtual nursing, virtual patient observation and advanced patient safety capabilities. The deployment will span more than 2,000 patient rooms and support a broad range of inpatient care environments. Through this partnership, Ardent Health will expand and standardize its existing virtual nursing and virtual care capabilities using hellocare.ai's AI Assisted Virtual Nursing, Telehealth and AI Assisted Virtual Patient Safety Monitoring modules, leveraging artificial
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2025 results after the market closes on Wednesday, March 4, 2026. A conference call will be held the following day, Thursday, March 5, 2026, at 10 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in o
The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Ardent Health, Inc. ("Ardent" or the "Company") (NYSE:ARDT) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On November 12, 2025, Ardent issued a press release announcing its financial results for the third quarter of 2025. In connection with that release, the Company disclosed that it recorded a $43 million reduction in revenue due to a change in accounting estimates regarding the collectability of accounts receivable. Ardent also rev
KeyBanc Capital Markets downgraded Ardent Health from Overweight to Sector Weight
Morgan Stanley downgraded Ardent Health from Overweight to Equal-Weight
Goldman initiated coverage of Ardent Health with a rating of Neutral and set a new price target of $19.00
8-K - Ardent Health, Inc. (0001756655) (Filer)
10-Q - Ardent Health, Inc. (0001756655) (Filer)
8-K - Ardent Health, Inc. (0001756655) (Filer)
4 - Ardent Health Partners, Inc. (0001756655) (Issuer)
4 - Ardent Health, Inc. (0001756655) (Issuer)
4 - Ardent Health, Inc. (0001756655) (Issuer)
4 - Ardent Health, Inc. (0001756655) (Issuer)
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2025 results after the market closes on Wednesday, March 4, 2026. A conference call will be held the following day, Thursday, March 5, 2026, at 10 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in o
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its third quarter 2025 results after the market closes on Wednesday, November 12, 2025. A conference call will be held the following day, Thursday, November 13, 2025, at 9 a.m. ET to review the Company's financial results and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its second quarter 2025 results after the market closes on Tuesday, August 5, 2025. A conference call will be held the following day, Wednesday, August 6, 2025, at 10 a.m. ET to review the company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)
SC 13G - Ardent Health Partners, Inc. (0001756655) (Subject)
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Chris Schoeplein as chief development officer. In this new role, Schoeplein will lead development efforts across Ardent's existing markets and support the organization's expansion into new regions. He will be responsible for driving growth across inpatient and outpatient care settings through acquisitions, partnerships and joint ventures. Additionally, he will guide due diligence, market intelligence and integration planning to advance Ardent's long-term growth strategy. "We are excited to welcome Chris to Ardent at a pivotal time in our gr
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence at an enterprise level. Caspers will also lead efforts to further optimize and scale the company's consumer-centric operating model across new and existing markets. "We are pleased to welcome Dave to Ardent," said Ardent Health President and CEO Marty Bonick. "His